1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6BF5B3D67C99BF06000258B43004F567A
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(FIELD+Subject+CONTAINS+%22launch%22)+AND+(%22launch%22)+and+(field+ItemCatalog=BMR)&SearchWV=1&SearchFuzzy=1&sort=relevance&Start=1&Count=10
18
19OpenForm&Query=(FIELD+Subject+CONTAINS+%22launch%22)+AND+(%22launch%22)+and+(field+ItemCatalog=BMR)&SearchWV=1&SearchFuzzy=1&sort=relevance&Start=1&Count=10
2044.192.48.196
21
22
23best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 1 - 10 of 37 Total Hits, Sorted by Relevance.

    |    

Product Re-Launch Excellence: Transforming Lackluster Pharmaceutical Products Into Market Success StoriesDirect access to this research is not included with your membership level.

Product re-launch is the hobgoblin of the pharmaceutical and biotech sector... (ID SM-170)
Companies Profiled: Bayer Healthcare, Sanofi-aventis, UCB Pharma, Schering-Plough, more ...

Digital Trends in Biopharma Launch Strategy and InvestmentDirect access to this research is not included with your membership level.

The pandemic created chaos for the launch plans of many biopharma companies, pushing them for the first time to fully integrate complete digital strategies into their traditional launch models... (ID PSM-375)
Companies Profiled: Amgen, Bending Brook LLC, Boehringer Ingelheim, Carl Zeiss Meditec, more ...

Pure Play Digital Launch: Launching a New Blockbuster Migraine Drug During a Global PandemicDirect access to this research is not included with your membership level.

In February 2020, Biohaven received FDA approval for Nurtec – a novel quick-dissolve oral drug that promises rapid relief from acute migraine and delivers sustained efficacy for two days... (ID PSM-374)
Companies Profiled: Biohaven Pharmaceuticals, AbbVie, Amgen, Eli Lilly, more ...

Building More Effective Medical Affairs Product Launch TeamsDirect access to this research is not included with your membership level.

Savvy Medical Affairs groups are increasingly taking center stage in launch preparations for new products... (ID POP-342)
Companies Profiled: Adamas Pharmaceuticals, Albireo, Alcon, Apellis Pharmaceuticals, more ...

Pharmaceutical Product Launch Evaluation Excellence: Processes and Measures to Evaluate Launch SuccessDirect access to this research is not included with your membership level.

Top pharma and biotech manufacturers have built launch systems which effectively assess launch performance and mitigate the risks associated with overspending or underfunding critical programs... (ID PSM-376)
Companies Profiled: Alcon, Amgen, APR Applied Pharma Research, Arvelle Therapeutics, more ...

Maximizing the Impact of Medical Affairs in Product LaunchDirect access to this research is not included with your membership level.

In the past decade, Medical Affairs has significantly evolved to play a critical role in launch success... (ID POP-311)
Companies Profiled: AbbVie, AcelRx, Alcon Laboratories, Alkermes, more ...

Medical Affairs Launch Excellence: Medical Affairs Role at Launch in Medical Device CompaniesDirect access to this research is not included with your membership level.

As a conduit between medical device organizations and key decision makers, the Medical Affairs function plays an important role in key product launch... (ID POP-274)
Companies Profiled: Abbott, Arthur F. Morelli and Associates, Axon Pharma, BARD Medical, more ...

Medical Affairs’ Role in Ensuring Excellence in Product LaunchDirect access to this research is not included with your membership level.

A successful product launch in today’s competitive and regulated marketplace is highly dependent on value-based and science-driven decision making... (ID POP-256)
Companies Profiled: Amgen, Insyght, Astellas, Incyte, more ...

Maximizing the Impact of Medical Affairs in Oncology Product LaunchesDirect access to this research is not included with your membership level.

The rapid pace of innovation in oncology therapeutics has led to intense competition between pharma companies to successfully launch their new products into the market... (ID POP-322)
Companies Profiled: AbbVie, Alkermes, AstraZeneca, Boehringer Ingelheim, more ...

Maximizing the Impact of Medical Affairs in Hematology Product LaunchesDirect access to this research is not included with your membership level.

Biopharma manufacturers seeking to differentiate their hematological therapies at launch are increasingly turning to their own medical experts... (ID POP-323)
Companies Profiled: AbbVie, Celgene, Crescendo Bioscience, Curis, more ...